TrialAnnals of the rheumatic diseases2017

A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study.

Sang-Cheol Bae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.